Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP1427)
Name
Estramustine
Synonyms
estramustine; 2998-57-4; Estramustina; Estramustinum; Emcyt; Estramustinum [INN-Latin]; Estramustina [INN-Spanish]; UNII-35LT29625A; Estradiol 3-(N,N-bis(2-chloroethyl)carbamate); 17beta-Estradiol 3-(bis(2-chloroethyl)carbamate); CHEMBL1575; Estradiol 3-[bis(2-chloroethyl)carbamate]; CHEBI:4868; NSC-89201; 35LT29625A; [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; LEO 275; NCGC00164581-01; Estradiol 3-(bis(2-chloroethyl)carbamate); Estradiol, 3-[bis(2-chloroethyl)carbamate]; Ro 22-2296/000; DSSTox_CID_26458; DSSTox_RID_81632; DSSTox_GSID_46458; (8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl bis(2-chloroethyl)carbamate; RO 21-8837; NSC 89201; estra-1,3,5(10)-triene-3,17beta-diol, 3-[bis(2-chloroethyl)carbamate]; C23H31Cl2NO3; CAS-2998-57-4; Estradiol, 3-(bis(2-chloroethyl)carbamate); Estradiol 3-[N,N-Bis(2-chloroethyl)carbamate]; MLS002701936; 17.beta.-Estradiol 3-[bis(2-chloroethyl)carbamate]; Estramustine (USAN/INN); estramustin; NSC89201; Estramustine [USAN:INN:BAN]; EINECS 221-076-3; SCHEMBL4252; Estramustin Sodium Phosphate; BIDD:GT0482; GTPL9076; DTXSID8046458; HMS3715D22; ZINC4099032; Tox21_112207; BDBM50333646; LMST02010038; (17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate; AKOS025402444; Tox21_112207_1; AC-9163; CCG-221220; DB01196; NCGC00164581-02; AS-12259; NCI60_041982; Ro-222296000; Ro-22-2296000; Ro-22-2296-000; C11228; D04066; 15163-EP2272827A1; 15163-EP2275420A1; 15163-EP2295055A2; 15163-EP2295416A2; 15163-EP2298748A2; 15163-EP2298764A1; 15163-EP2298765A1; 15163-EP2305642A2; 15163-EP2308833A2; 15163-EP2308861A1; 15163-EP2311453A1; 15163-EP2311840A1; 15163-EP2316832A1; 15163-EP2316833A1; 998E574; Q412939; W-106963; Carbamic acid, bis(2-chloroethyl)-, 17beta-hydroxyestra-1,3,5(10)-trien-3-yl ester; Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate) (9CI); Estra-1,3,5(10)-triene-3,17-diol, 3-(bis(2-chloroethyl)carbamate), (17beta)-; Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate]; Estra-1,5(10)-triene-3,17-diol, 3-[bis(2-chloroethyl)carbamate], (17.beta.)-; Bis-(2-chloro-ethyl)-carbamic acid 17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl ester
    Click to Show/Hide
Species Origin Homo sapiens ...     Click to Show/Hide
Homo sapiens
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Disease Prostate cancer [ICD-11: 2C82] Approved [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C23H31Cl2NO3
PubChem CID
259331
Canonical SMILES
CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
InChI
1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1
InChIKey
FRPJXPJMRWBBIH-RBRWEJTLSA-N
CAS Number
CAS 2998-57-4
ChEBI ID
CHEBI:4868
TTD Drug ID
D03SRY
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Docetaxel      Solid tumour/cancer     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    In-vitro Model PC-3 CVCL_0035 Prostate carcinoma Homo sapiens
LNCaP CVCL_0395 Prostate carcinoma Homo sapiens
                    Experimental
                    Result(s)
These results provide novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.
Target and Pathway
Target(s) Estramustine binding protein (EMBP)  Molecule Info  [3]
References
Reference 1 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
Reference 2 Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther. 2005 Mar;4(3):389-98.
Reference 3 Estramustine binding protein in primary tumours and metastases of malignant melanoma. Melanoma Res. 1994 Dec;4(6):401-5.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China